DSpace Repository
A study of efficacy of new generation atypical antipsychotic (lurasidone) across positive & negative symptom-domains in fresh cases of schizophrenia.
- DSpace Home
- →
- Faculty Publications
- →
- Medical
- →
- Journal Article Publications
- →
- Faculty of Psychiatry
- →
- View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Darshan Yallappa Jotibannad, Abhishek N, Manovijay B Kalasagond, Vijayraj N. | |
| dc.date.accessioned | 2022-11-08T07:34:13Z | |
| dc.date.available | 2022-11-08T07:34:13Z | |
| dc.date.issued | 2022 | |
| dc.identifier.citation | Darshan Yallappa Jotibannad, Abhishek N, Manovijay B Kalasagond, Vijayraj N. A study of efficacy of new generation atypical antipsychotic (lurasidone) across positive & negative symptom-domains in fresh cases of schizophrenia. Journal of Cardiovascular Disease Research. 13(3): 31-37, 2022. | en_US |
| dc.identifier.issn | 09753583 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/4494 | |
| dc.language.iso | en | en_US |
| dc.title | A study of efficacy of new generation atypical antipsychotic (lurasidone) across positive & negative symptom-domains in fresh cases of schizophrenia. | en_US |
| dc.type | Article | en_US |
